JD Health International Inc.
6618
Rank in Stocks
#1394
JD Health International Inc., functioning as an investment holding entity, runs... JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Share Price
$4.96
Market Cap
$15.82B
Change (1 day)
-2.58%
Change (1 year)
-40.00%
Country
CN
Trade JD Health International Inc. (6618)
Category
Healthcare
Revenue for JD Health International Inc. (6618)
Revenue in Jun 2026 TTM: $11.37B
According to JD Health International Inc. latest financial reports the company's current revenue (TTM) is $11.37B. In 2023 the company made a revenue of $7.56B an increase over the revenue in the year 2022 that was $6.78B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for JD Health International Inc. from 2017 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $11.37B | 42.72% |
| 2024 | $7.97B | 5.37% |
| 2023 | $7.56B | 11.61% |
| 2022 | $6.78B | 40.35% |
| 2021 | $4.83B | 62.70% |
| 2020 | $2.97B | 90.55% |
| 2019 | $1.56B | 31.11% |
| 2018 | $1.19B | 39.14% |
| 2017 | $853.51M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $78.01B | 586.00% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 91.80% |
US
|
|
| $3.89B | -65.75% |
SA
|
|
| $11.08B | -2.53% |
BR
|
